FDA Approves Auto-Injector for Migraine, Cluster Headache

(MedPage Today) -- The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday.
The prefilled syringe formulation...